The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.23BCNY
481.52M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
73.25x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
975.85MCNY
145.62M · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
4.31%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Beta
1.41x
vs all stocks
Updated Sep 20, 2026
52-Week Change
-9.19%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
3.23BCNY
481.52M · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
3.29BCNY
491.26M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
73.25x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Forward P/E
4.78x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Sales (TTM)
3.31x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Book (MRQ)
11.34x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to Revenue
3.37x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to EBITDA
42.86x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 49.18×.Updated Sep 20, 2026
Gross Margin
26.35%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Profit Margin
4.31%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Margin
1.89%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Assets (TTM)
2.46%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Equity (TTM)
15.24%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
975.85MCNY
145.62M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
2.84CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
21.00%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Gross Profit (TTM)
264.35MCNY
39.45M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
66.94MCNY
9.99M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
42.02MCNY
6.27M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
28.90%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Cash Flow (TTM)
110.62MCNY
16.51M · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
108.31MCNY
16.16M · vs all stocks (USD)
Updated Sep 20, 2026
Payout Ratio
0.00%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Minority Interest (Equity)
-180.02KCNYFY2025 · Dec 31, 2025
Revenue
869.22MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
597.83MCNYFY2025 · Dec 31, 2025
Gross Profit
271.40MCNYFY2025 · Dec 31, 2025
Operating Income
55.06MCNY
8.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
34.81MCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.64MCNYFY2025 · Dec 31, 2025
Net Income
33.17MCNYFY2025 · Dec 31, 2025
EBIT
50.33MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
64.23MCNYFY2025 · Dec 31, 2025
Research & Development
39.18MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
50.27MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
9.74MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
825.26KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
15.52MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.1000CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.1000CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
367.76MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
367.76MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
33.17MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
3.61MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
20.45MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-38.60MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
121.38MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
33.17MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
19.30MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-54.84MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
22.83MCNYFY2025 · Dec 31, 2025
Capital Expenditures
59.05MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-10.87MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
48.18MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
339.84MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-340.50MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-13.88MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-16.56MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-31.10MCNYFY2025 · Dec 31, 2025
Shares Outstanding
367.11MSharesUpdated Sep 20, 2026
Float Shares
283.69MSharesUpdated Sep 20, 2026
% Held by Insiders
24.38%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
1.34%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
251.72MCNY
37.56M · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
0.6860CNYUpdated Sep 20, 2026
Total Debt (MRQ)
313.00MCNY
46.71M · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
1.09x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Current Ratio (MRQ)
1.13x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Book Value per Share (MRQ)
0.7750CNYUpdated Sep 20, 2026
Total Assets
1.43BCNY
213.17M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.15BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.17BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
280.44MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
154.54MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.01BCNYFY2025 · Dec 31, 2025
Cash
133.39MCNYFY2025 · Dec 31, 2025
Cash Equivalents
48.00MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
181.39MCNYFY2025 · Dec 31, 2025
Accounts Receivable
263.43MCNYFY2025 · Dec 31, 2025
Inventory
503.18MCNYFY2025 · Dec 31, 2025
Accounts Payable
309.96MCNYFY2025 · Dec 31, 2025
Short-term Debt
236.74MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
51.61MCNYFY2025 · Dec 31, 2025
Long-term Debt
120.20MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
15.42MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
367.11MCNYFY2025 · Dec 31, 2025
Retained Earnings
-1.27BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
262.81MCNY
39.22M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
5.90CNYUpdated Sep 20, 2026
52-Week High
13.62CNYUpdated Sep 20, 2026
52-Week Change
-9.19%
vs all stocks
Updated Sep 20, 2026
Beta
1.41x
vs all stocks
Updated Sep 20, 2026
50-Day MA
7.76CNYUpdated Sep 20, 2026
200-Day MA
9.05CNYUpdated Sep 20, 2026
Avg 10-Day Volume
26.16MSharesUpdated Sep 20, 2026
Avg 30-Day Volume
18.77MSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
0.1200CNYUpdated Sep 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.13×, lower than 95% of its Scientific & Technical Instruments peers (median 2.38×)Significant
Current ratio: 1.13Industry median: 2.38Industry P5: 1.36Peers compared: 64.00
Debt-to-equity is 1.09×, higher than 95% of its Scientific & Technical Instruments peers (median 0.13×)Significant